Rectal prolapse in pediatrics

Constantinos Siafakas, Theodore P. Vottler, John M. Andersen

Research output: Contribution to journalArticle

73 Citations (Scopus)

Abstract

Rectal prolapse in pediatrics has its highest incidence in infancy and is uncommonly seen in industrialized countries. The prolapse may involve only the mucosa (mucosal prolapse) or all layers of the rectum (complete prolapse or procidentia). It is usually detected by the child's parents and is brought urgently to medical attention; however, it is usually spontaneously reduced by the time they reach the practitioner's office. Rectal prolapse should be viewed as a symptom of an underlying condition rather than a discrete disease entity. Potential causes are increased intraabdominal pressure, diarrheal and neoplastic diseases, malnutrition, and conditions predisposing to pelvic floor weakness. Its strong association with cystic fibrosis makes the sweat test mandatory for infants and children with recurrent rectal prolapse. Of particular importance are three entities related to rectal prolapse that may easily escape diagnosis by practitioner: occult rectal prolapse, solitary ulcer of the rectum syndrome, and inflammatory cloacogenic polyps. The treatment of rectal prolapse is mainly conservative and is directed at the underlying conditions. Surgical intervention may be required for recurrent rectal prolapse refractory to conservative measures. The simplest, less invasive, yet highly effective approach, appears to be perirectal injection with a sclerosing agent. While the majority of children experience spontaneous resolution of the prolapse, the prognosis is worse when presentation occurs after the age of 4 years.

Original languageEnglish (US)
Pages (from-to)63-72
Number of pages10
JournalClinical Pediatrics
Volume38
Issue number2
StatePublished - 1999

Fingerprint

Rectal Prolapse
Pediatrics
Prolapse
Rectum
Sclerosing Solutions
Pelvic Floor
Sweat
Polyps
Developed Countries
Cystic Fibrosis
Malnutrition
Ulcer
Mucous Membrane
Parents
Pressure
Injections
Incidence

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Siafakas, C., Vottler, T. P., & Andersen, J. M. (1999). Rectal prolapse in pediatrics. Clinical Pediatrics, 38(2), 63-72.

Rectal prolapse in pediatrics. / Siafakas, Constantinos; Vottler, Theodore P.; Andersen, John M.

In: Clinical Pediatrics, Vol. 38, No. 2, 1999, p. 63-72.

Research output: Contribution to journalArticle

Siafakas, C, Vottler, TP & Andersen, JM 1999, 'Rectal prolapse in pediatrics', Clinical Pediatrics, vol. 38, no. 2, pp. 63-72.
Siafakas C, Vottler TP, Andersen JM. Rectal prolapse in pediatrics. Clinical Pediatrics. 1999;38(2):63-72.
Siafakas, Constantinos ; Vottler, Theodore P. ; Andersen, John M. / Rectal prolapse in pediatrics. In: Clinical Pediatrics. 1999 ; Vol. 38, No. 2. pp. 63-72.
@article{0ff41cc8736a40f287b38fd714d8d472,
title = "Rectal prolapse in pediatrics",
abstract = "Rectal prolapse in pediatrics has its highest incidence in infancy and is uncommonly seen in industrialized countries. The prolapse may involve only the mucosa (mucosal prolapse) or all layers of the rectum (complete prolapse or procidentia). It is usually detected by the child's parents and is brought urgently to medical attention; however, it is usually spontaneously reduced by the time they reach the practitioner's office. Rectal prolapse should be viewed as a symptom of an underlying condition rather than a discrete disease entity. Potential causes are increased intraabdominal pressure, diarrheal and neoplastic diseases, malnutrition, and conditions predisposing to pelvic floor weakness. Its strong association with cystic fibrosis makes the sweat test mandatory for infants and children with recurrent rectal prolapse. Of particular importance are three entities related to rectal prolapse that may easily escape diagnosis by practitioner: occult rectal prolapse, solitary ulcer of the rectum syndrome, and inflammatory cloacogenic polyps. The treatment of rectal prolapse is mainly conservative and is directed at the underlying conditions. Surgical intervention may be required for recurrent rectal prolapse refractory to conservative measures. The simplest, less invasive, yet highly effective approach, appears to be perirectal injection with a sclerosing agent. While the majority of children experience spontaneous resolution of the prolapse, the prognosis is worse when presentation occurs after the age of 4 years.",
author = "Constantinos Siafakas and Vottler, {Theodore P.} and Andersen, {John M.}",
year = "1999",
language = "English (US)",
volume = "38",
pages = "63--72",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Rectal prolapse in pediatrics

AU - Siafakas, Constantinos

AU - Vottler, Theodore P.

AU - Andersen, John M.

PY - 1999

Y1 - 1999

N2 - Rectal prolapse in pediatrics has its highest incidence in infancy and is uncommonly seen in industrialized countries. The prolapse may involve only the mucosa (mucosal prolapse) or all layers of the rectum (complete prolapse or procidentia). It is usually detected by the child's parents and is brought urgently to medical attention; however, it is usually spontaneously reduced by the time they reach the practitioner's office. Rectal prolapse should be viewed as a symptom of an underlying condition rather than a discrete disease entity. Potential causes are increased intraabdominal pressure, diarrheal and neoplastic diseases, malnutrition, and conditions predisposing to pelvic floor weakness. Its strong association with cystic fibrosis makes the sweat test mandatory for infants and children with recurrent rectal prolapse. Of particular importance are three entities related to rectal prolapse that may easily escape diagnosis by practitioner: occult rectal prolapse, solitary ulcer of the rectum syndrome, and inflammatory cloacogenic polyps. The treatment of rectal prolapse is mainly conservative and is directed at the underlying conditions. Surgical intervention may be required for recurrent rectal prolapse refractory to conservative measures. The simplest, less invasive, yet highly effective approach, appears to be perirectal injection with a sclerosing agent. While the majority of children experience spontaneous resolution of the prolapse, the prognosis is worse when presentation occurs after the age of 4 years.

AB - Rectal prolapse in pediatrics has its highest incidence in infancy and is uncommonly seen in industrialized countries. The prolapse may involve only the mucosa (mucosal prolapse) or all layers of the rectum (complete prolapse or procidentia). It is usually detected by the child's parents and is brought urgently to medical attention; however, it is usually spontaneously reduced by the time they reach the practitioner's office. Rectal prolapse should be viewed as a symptom of an underlying condition rather than a discrete disease entity. Potential causes are increased intraabdominal pressure, diarrheal and neoplastic diseases, malnutrition, and conditions predisposing to pelvic floor weakness. Its strong association with cystic fibrosis makes the sweat test mandatory for infants and children with recurrent rectal prolapse. Of particular importance are three entities related to rectal prolapse that may easily escape diagnosis by practitioner: occult rectal prolapse, solitary ulcer of the rectum syndrome, and inflammatory cloacogenic polyps. The treatment of rectal prolapse is mainly conservative and is directed at the underlying conditions. Surgical intervention may be required for recurrent rectal prolapse refractory to conservative measures. The simplest, less invasive, yet highly effective approach, appears to be perirectal injection with a sclerosing agent. While the majority of children experience spontaneous resolution of the prolapse, the prognosis is worse when presentation occurs after the age of 4 years.

UR - http://www.scopus.com/inward/record.url?scp=0033018953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033018953&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 63

EP - 72

JO - Clinical Pediatrics

JF - Clinical Pediatrics

SN - 0009-9228

IS - 2

ER -